What is it about?
The use of subcutaneous mini-dose glucagon (MDG) during Ramadan is an effective and superior to oral glucose as immediate treatment and prevention for fasting-induced hypoglycemia. Furthermore, MDG can improve glycaemic control and promote the successful completion of fasts in Ramadan.
Featured Image
Read the Original
This page is a summary of: Home Use of Mini-Dose Glucagon As a Novel Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan, Diabetes Care, February 2022, American Diabetes Association,
DOI: 10.2337/dc21-1655.
You can read the full text:
Contributors
Be the first to contribute to this page
